Abstract:Glioblastoma multiforme (GBM) is the most malignant and aggressive primary brain tumor in adults. Despite concerted efforts to improve current therapies, the prognosis of glioblastoma remains very poor. Alantolactone, a sesquiterpene lactone compound, has been reported to exhibit antifungal, antibacteria, antihelminthic, and anticancer properties. In this study, we found that alantolactone effectively inhibits growth and triggers apoptosis in glioblastoma cells in a time- and dose-dependent manner. The alantolactone-induced apoptosis was found to be associated with glutathione (GSH) depletion, reactive oxygen species (ROS) generation, mitochondrial transmembrane potential dissipation, cardiolipin oxidation, upregulation of p53 and Bax, downregulation of Bcl-2, cytochrome c release, activation of caspases (caspase 9 and 3), and cleavage of poly (ADP-ribose) polymerase. This alantolactone-induced apoptosis and GSH depletion were effectively inhibited or abrogated by a thiol antioxidant, N-acetyl-L-cysteine, whereas other antioxidant (polyethylene glycol (PEG)-catalase and PEG-superoxide-dismutase) did not prevent apoptosis and GSH depletion. Alantolactone treatment inhibited the translocation of NF-?B into nucleus; however, NF-?B inhibitor, SN50 failed to potentiate alantolactone-induced apoptosis indicating that alantolactone induces NF-?B-independent apoptosis in glioma cells. These findings suggest that the sensitivity of tumor cells to alantolactone appears to results from GSH depletion and ROS production. Furthermore, our in vivo toxicity study demonstrated that alantolactone did not induce significant hepatotoxicity and nephrotoxicity in mice. Therefore, alantolactone may become a potential lead compound for future development of antiglioma therapy. (c) 2012 IUBMB Life, 64(9): 783794, 2012

Apoptosis-promoting and Migration-Suppressing Effect of Alantolactone on Gastric Cancer Cell Lines BGC-823 and SGC-7901 Via Regulating P38mapk and NF-κB Pathways

The Inhibiting Effect of Combination of Allicin with Paclitaxel on Proliferation of Gastric Cancer Cells and Promotion of Apoptosis

Alantolactone Induces Apoptosis and Suppresses Migration in MCF‑7 Human Breast Cancer Cells Via the P38mapk, NF‑κB and Nrf2 Signaling Pathways

Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer Sk-Mes-1 Cells

Alantolactone Exhibits Antiproliferative and Apoptosis-Promoting Properties in Colon Cancer Model Via Activation of the MAPK-JNK/c-Jun Signaling Pathway

Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway

Alantolactone Induces Apoptosis in RKO Cells Through the Generation of Reactive Oxygen Species and the Mitochondrial Pathway

Alantolactone Induces Activation of Apoptosis in Human Hepatoma Cells.

Antitumor activity of alantolactone in lung cancer cell lines NCI-H1299 and Anip973.

Alantolactone Induces Apoptosis and Improves Chemosensitivity of Pancreatic Cancer Cells by Impairment of Autophagy-Lysosome Pathway Via Targeting TFEB

Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.

Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

Alantolactone Induces Cell Apoptosis Partially Through Down-Regulation of Testes-Specific Protease 50 Expression

Alantolactone Induces Apoptosis Through ROS-mediated AKT Pathway and Inhibition of PINK1-mediated Mitophagy in Human HepG2 Cells.

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Alantolactone inhibits cervical cancer progression by downregulating BMI1

Atractylode inhibits proliferation and promotes apoptosis in gastric cancer cell line SGC-7901

Anticancer Effects of Lanostane Against Human Gastric Cancer Cells Involves Autophagy, Apoptosis and Modulation of M-Tor/pi3k/akt Signalling Pathway.

Inhibitory Effects of Natural Compound Alantolactone on Human Non-small Cell Lung Cancer A549 Cells